Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Shohet

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 1999
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrationsR V Shohet, G L Vega, A Anwar, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Cloning of the cDNA encoding the myosin heavy chain of a vertebrate cellular myosinR V Shohet, M A Conti, S Kawamoto, et al.
Gene Therapy|April 15, 2005
Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubblesG Korpanty, S Chen, R V Shohet, et al.
Circulation|June 7, 2000
Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardiumR V Shohet, S Chen, Y T Zhou, et al.
American Journal of Human Genetics|July 13, 2000
Repeat polymorphisms within gene regions: phenotypic and evolutionary implicationsJ D Wren, E Forgacs, J W Fondon, et al.
Mucosal Immunology|May 18, 2017
An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infectionK M Akram, N A Moyo, G H Leeming, et al.
Mucosal Immunology|May 31, 2018
An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infectionK M Akram, N A Moyo, G H Leeming, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 1999
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrationsR V Shohet, G L Vega, A Anwar, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Cloning of the cDNA encoding the myosin heavy chain of a vertebrate cellular myosinR V Shohet, M A Conti, S Kawamoto, et al.
Gene Therapy|April 15, 2005
Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubblesG Korpanty, S Chen, R V Shohet, et al.
Circulation|June 7, 2000
Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardiumR V Shohet, S Chen, Y T Zhou, et al.
American Journal of Human Genetics|July 13, 2000
Repeat polymorphisms within gene regions: phenotypic and evolutionary implicationsJ D Wren, E Forgacs, J W Fondon, et al.
Mucosal Immunology|May 18, 2017
An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infectionK M Akram, N A Moyo, G H Leeming, et al.
Mucosal Immunology|May 31, 2018
An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infectionK M Akram, N A Moyo, G H Leeming, et al.
Pageof 2